サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1726631

歯科用抗炎症薬の世界市場に関する洞察、2031年までの予測

Global Dental Anti-inflammatory Drugs Market Insights, Forecast to 2031

出版日
発行
QYResearch
ページ情報
英文 150 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.32円
歯科用抗炎症薬の世界市場に関する洞察、2031年までの予測
出版日: 2025年05月19日
発行: QYResearch
ページ情報: 英文 150 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、歯科用抗炎症薬 (Dental Anti-inflammatory Drugs) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 歯科用抗炎症薬の製品概要
  • 市場：タイプ別
    • 世界の歯科用抗炎症薬の市場規模成長率：タイプ別, 2020 VS 2024 VS 2031
    • Antibiotics
    • Non-steroidal Anti-inflammatory Drugs
    • Steroidal Anti-inflammatory Drugs
    • Others
  • 市場：用途別
    • 世界の歯科用抗炎症薬の市場規模成長率：用途別, 2020 VS 2024 VS 2031
    • Online Sales
    • Hospitals
    • Pharmacies
    • Clinics
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の歯科用抗炎症薬の収益 推定および予測 2020-2031
  • 世界の収益：地域別
    • 世界の歯科用抗炎症薬 収益：地域別: 2020 VS 2024 VS 2031
    • 世界の歯科用抗炎症薬 収益：地域別 (2020-2031)
    • 世界の歯科用抗炎症薬の収益市場シェア 地域別 (2020-2031)
  • 世界の歯科用抗炎症薬 売上予測・予想 2020-2031
  • 世界の販売：地域別
    • 世界の歯科用抗炎症薬 販売：地域別: 2020 VS 2024 VS 2031
    • 世界の歯科用抗炎症薬 販売：地域別 (2020-2031)
    • 世界の歯科用抗炎症薬の販売市場シェア 地域別 (2020-2031)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界の販売：企業別
    • 世界の歯科用抗炎症薬 販売：企業別 (2020-2025)
    • 世界の歯科用抗炎症薬の販売市場シェア：企業別 (2020-2025)
    • 世界の上位10・上位5企業： 歯科用抗炎症薬 2024年
  • 世界の収益：企業別
    • 世界の歯科用抗炎症薬 収益：企業別 (2020-2025)
    • 世界の歯科用抗炎症薬の収益市場シェア：企業別 (2020-2025)
    • 世界の上位10・上位5企業： 歯科用抗炎症薬 収益 2024年
  • 世界の主要企業 歯科用抗炎症薬, 業界ランキング, 2023 VS 2024
  • 世界の歯科用抗炎症薬の販売価格：企業別 (2020-2025)
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の歯科用抗炎症薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 歯科用抗炎症薬, 製造拠点分布と本社
  • 世界の主要メーカー 歯科用抗炎症薬, 提供製品と用途
  • 世界の主要メーカー 歯科用抗炎症薬, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の販売：タイプ別
    • 世界の歯科用抗炎症薬の販売実績：タイプ別 (2020-2025)
    • 世界の歯科用抗炎症薬の販売予測：タイプ別 (2026-2031)
    • 世界の歯科用抗炎症薬の販売市場シェア：タイプ別 (2020-2031)
  • 世界の収益：タイプ別
    • 世界の歯科用抗炎症薬の収益実績：タイプ別 (2020-2025)
    • 世界の歯科用抗炎症薬の収益予測：タイプ別 (2026-2031)
    • 世界の歯科用抗炎症薬の収益市場シェア：タイプ別 (2020-2031)
  • 世界の価格：タイプ別
    • 世界の歯科用抗炎症薬 価格：タイプ別 (2020-2025)
    • 世界の歯科用抗炎症薬の価格予測：タイプ別 (2026-2031)

第5章 市場規模：用途別

  • 世界の販売：用途別
    • 世界の歯科用抗炎症薬の販売実績：用途別 (2020-2025)
    • 世界の歯科用抗炎症薬の販売予測：用途別 (2026-2031)
    • 世界の歯科用抗炎症薬の販売市場シェア：用途別 (2020-2031)
  • 世界の収益：用途別
    • 世界の歯科用抗炎症薬の収益実績：用途別 (2020-2025)
    • 世界の歯科用抗炎症薬の収益予測：用途別 (2026-2031)
    • 世界の歯科用抗炎症薬の収益市場シェア：用途別 (2020-2031)
  • 世界の価格：用途別
    • 世界の歯科用抗炎症薬 価格：用途別 (2020-2025)
    • 世界の歯科用抗炎症薬の価格予測：用途別 (2026-2031)

第6章 米国・カナダ

  • 米国・カナダ 市場規模：タイプ別
    • 米国・カナダ 歯科用抗炎症薬 販売：タイプ別 (2020-2031)
    • 米国・カナダ 歯科用抗炎症薬 収益：タイプ別 (2020-2031)
  • 米国・カナダ 市場規模：用途別
    • 米国・カナダ 歯科用抗炎症薬 販売：用途別 (2020-2031)
    • 米国・カナダ 歯科用抗炎症薬 収益：用途別 (2020-2031)
  • 米国・カナダ 市場規模：国別
    • 米国・カナダ 歯科用抗炎症薬の収益：国別: 2020 VS 2024 VS 2031
    • 米国・カナダ 歯科用抗炎症薬の収益：国別 (2020-2031)
    • 米国・カナダ 歯科用抗炎症薬の販売：国別 (2020-2031)
    • US
    • カナダ

第7章 欧州

  • 欧州の市場規模：タイプ別
    • 欧州の歯科用抗炎症薬 販売：タイプ別 (2020-2031)
    • 欧州の歯科用抗炎症薬 収益：タイプ別 (2020-2031)
  • 欧州の市場規模：用途別
    • 欧州の歯科用抗炎症薬 販売：用途別 (2020-2031)
    • 欧州の歯科用抗炎症薬 収益：用途別 (2020-2031)
  • 欧州の市場規模：国別
    • 欧州の歯科用抗炎症薬の収益：国別: 2020 VS 2024 VS 2031
    • 欧州の歯科用抗炎症薬の販売：国別 (2020-2031)
    • 欧州の歯科用抗炎症薬の収益：国別 (2020-2031)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国の市場規模：タイプ別
    • 中国の歯科用抗炎症薬 販売：タイプ別 (2020-2031)
    • 中国の歯科用抗炎症薬 収益：タイプ別 (2020-2031)
  • 中国の市場規模：用途別
    • 中国の歯科用抗炎症薬 販売：用途別 (2020-2031)
    • 中国の歯科用抗炎症薬 収益：用途別 (2020-2031)

第9章 アジア（中国を除く）

  • アジア地域 市場規模：タイプ別
    • アジア地域 歯科用抗炎症薬 販売：タイプ別 (2020-2031)
    • アジア地域 歯科用抗炎症薬 収益：タイプ別 (2020-2031)
  • アジア地域 市場規模：用途別
    • アジア地域 歯科用抗炎症薬 販売：用途別 (2020-2031)
    • アジア地域 歯科用抗炎症薬 収益：用途別 (2020-2031)
  • アジア地域 市場規模：地域別
    • アジア地域 歯科用抗炎症薬 収益：地域別: 2020 VS 2024 VS 2031
    • アジア地域 歯科用抗炎症薬 収益：地域別 (2020-2031)
    • アジア地域 歯科用抗炎症薬 販売：地域別 (2020-2031)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカの歯科用抗炎症薬 販売：タイプ別 (2020-2031)
    • 中東, アフリカ ・ラテンアメリカの歯科用抗炎症薬 収益：タイプ別 (2020-2031)
  • 中東, アフリカ ・ラテンアメリカの市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカの歯科用抗炎症薬 販売：用途別 (2020-2031)
    • 中東, アフリカ ・ラテンアメリカの歯科用抗炎症薬 収益：用途別 (2020-2031)
  • 中東, アフリカ ・ラテンアメリカの市場規模：国別
    • 中東, アフリカ ・ラテンアメリカの歯科用抗炎症薬の収益：国別: 2020 VS 2024 VS 2031
    • 中東, アフリカ ・ラテンアメリカの歯科用抗炎症薬の収益：国別 (2020-2031)
    • 中東, アフリカ ・ラテンアメリカの歯科用抗炎症薬の販売：国別 (2020-2031)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • 3M
  • DenMat
  • Merck
  • Bayer
  • Sunstar
  • GSK
  • Bausch Health
  • Colgate-Palmolive
  • Johnson & Johnson
  • Roche
  • Septodont
  • Acteon
  • China Resources Double Crane Pharmaceuticals
  • Yunnan Baiyao Group
  • Hengrui Medicine

第12章 業界チェーンと販売チャネルの分析

  • 歯科用抗炎症薬 業界チェーン分析
  • 歯科用抗炎症薬 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 歯科用抗炎症薬 生産形態とプロセス
  • 歯科用抗炎症薬 販売およびマーケティング
    • 歯科用抗炎症薬 販売チャネルs
    • 歯科用抗炎症薬 卸業者
  • 歯科用抗炎症薬 顧客

第13章 歯科用抗炎症薬 市場動向

  • 歯科用抗炎症薬 業界動向
  • 歯科用抗炎症薬 市場の促進要因
  • 歯科用抗炎症薬 市場の課題
  • 歯科用抗炎症薬 市場の抑制要因

第14章 主な調査結果 世界の歯科用抗炎症薬の主な市場調査結果

第15章 付録

図表

List of Tables

Table 1. Global Dental Anti-inflammatory Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Major Manufacturers of Antibiotics

Table 3. Major Manufacturers of Non-steroidal Anti-inflammatory Drugs

Table 4. Major Manufacturers of Steroidal Anti-inflammatory Drugs

Table 5. Major Manufacturers of Others

Table 6. Global Dental Anti-inflammatory Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 7. Global Dental Anti-inflammatory Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 8. Global Revenue by Region (2020-2025) & (US$ Million)

Table 9. Global Revenue Market Share by Region (2020-2031)

Table 10. Global Dental Anti-inflammatory Drugs Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 11. Global Dental Anti-inflammatory Drugs Sales by Region (2020-2031) & (K Units)

Table 12. Global Sales Market Share by Region (2020-2031)

Table 13. Global Dental Anti-inflammatory Drugs Sales by Manufacturers (2020-2025) & (K Units)

Table 14. Global Dental Anti-inflammatory Drugs Sales Share by Manufacturers (2020-2025)

Table 15. Global Dental Anti-inflammatory Drugs Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Dental Anti-inflammatory Drugs Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Players of Dental Anti-inflammatory Drugs, Industry Ranking, 2023 VS 2024 VS 2024

Table 18. Dental Anti-inflammatory Drugs Price by Manufacturers (2020-2025) & (US$/Unit)

Table 19. Global Dental Anti-inflammatory Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 20. Global Dental Anti-inflammatory Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dental Anti-inflammatory Drugs as of 2024)

Table 21. Global Key Manufacturers of Dental Anti-inflammatory Drugs, Manufacturing Base Distribution and Headquarters

Table 22. Global Key Manufacturers of Dental Anti-inflammatory Drugs, Product Offered and Application

Table 23. Global Key Manufacturers of Dental Anti-inflammatory Drugs, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Dental Anti-inflammatory Drugs Sales by Type (2020-2025) & (K Units)

Table 26. Global Dental Anti-inflammatory Drugs Sales by Type (2026-2031) & (K Units)

Table 27. Global Sales Share by Type (2020-2031)

Table 28. Global Dental Anti-inflammatory Drugs Revenue by Type (2020-2025) & (US$ Million)

Table 29. Global Dental Anti-inflammatory Drugs Revenue by Type (2026-2031) & (US$ Million)

Table 30. Global Revenue Share by Type (2020-2031)

Table 31. Dental Anti-inflammatory Drugs Price by Type (2020-2025) & (US$/Unit)

Table 32. Global Dental Anti-inflammatory Drugs Price Forecast by Type (2026-2031) & (US$/Unit)

Table 33. Global Dental Anti-inflammatory Drugs Sales by Application (2020-2025) & (K Units)

Table 34. Global Dental Anti-inflammatory Drugs Sales by Application (2026-2031) & (K Units)

Table 35. Global Sales Share by Application (2020-2031)

Table 36. Global Dental Anti-inflammatory Drugs Revenue by Application (2020-2025) & (US$ Million)

Table 37. Global Dental Anti-inflammatory Drugs Revenue by Application (2026-2031) & (US$ Million)

Table 38. Global Revenue Share by Application (2020-2031)

Table 39. Dental Anti-inflammatory Drugs Price by Application (2020-2025) & (US$/Unit)

Table 40. Global Dental Anti-inflammatory Drugs Price Forecast by Application (2026-2031) & (US$/Unit)

Table 41. US & Canada Sales by Type (2020-2031) & (K Units)

Table 42. US & Canada Revenue by Type (2020-2031) & (US$ Million)

Table 43. US & Canada Sales by Application (2020-2031) & (K Units)

Table 44. US & Canada Revenue by Application (2020-2031) & (US$ Million)

Table 45. US & Canada Dental Anti-inflammatory Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. US & Canada Revenue by Country (2020-2031) & (US$ Million)

Table 47. US & Canada Sales by Country (2020-2031) & (K Units)

Table 48. Europe Sales by Type (2020-2031) & (K Units)

Table 49. Europe Revenue by Type (2020-2031) & (US$ Million)

Table 50. Europe Sales by Application (2020-2031) & (K Units)

Table 51. Europe Revenue by Application (2020-2031) & (US$ Million)

Table 52. Europe Dental Anti-inflammatory Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 53. Europe Sales by Country (2020-2031) & (K Units)

Table 54. Europe Revenue by Country (2020-2031) & (US$ Million)

Table 55. China Sales by Type (2020-2031) & (K Units)

Table 56. China Revenue by Type (2020-2031) & (US$ Million)

Table 57. China Sales by Application (2020-2031) & (K Units)

Table 58. China Revenue by Application (2020-2031) & (US$ Million)

Table 59. Asia Sales by Type (2020-2031) & (K Units)

Table 60. Asia Revenue by Type (2020-2031) & (US$ Million)

Table 61. Asia Sales by Application (2020-2031) & (K Units)

Table 62. Asia Revenue by Application (2020-2031) & (US$ Million)

Table 63. Asia Dental Anti-inflammatory Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 64. Asia Revenue by Region (2020-2031) & (US$ Million)

Table 65. Asia Sales by Region (2020-2031) & (K Units)

Table 66. Middle East, Africa and Latin America Sales by Type (2020-2031) & (K Units)

Table 67. Middle East, Africa and Latin America Revenue by Type (2020-2031) & (US$ Million)

Table 68. Middle East, Africa and Latin America Sales by Application (2020-2031) & (K Units)

Table 69. Middle East, Africa and Latin America Revenue by Application (2020-2031) & (US$ Million)

Table 70. Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 71. Middle East, Africa and Latin America Revenue by Country (2020-2031) & (US$ Million)

Table 72. Middle East, Africa and Latin America Sales by Country (2020-2031) & (K Units)

Table 73. 3M Company Information

Table 74. 3M Description and Major Businesses

Table 75. 3M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 76. 3M Product Model Numbers, Pictures, Descriptions and Specifications

Table 77. 3M Recent Developments

Table 78. DenMat Company Information

Table 79. DenMat Description and Major Businesses

Table 80. DenMat Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. DenMat Product Model Numbers, Pictures, Descriptions and Specifications

Table 82. DenMat Recent Developments

Table 83. Merck Company Information

Table 84. Merck Description and Major Businesses

Table 85. Merck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 86. Merck Product Model Numbers, Pictures, Descriptions and Specifications

Table 87. Merck Recent Developments

Table 88. Bayer Company Information

Table 89. Bayer Description and Major Businesses

Table 90. Bayer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 91. Bayer Product Model Numbers, Pictures, Descriptions and Specifications

Table 92. Bayer Recent Developments

Table 93. Sunstar Company Information

Table 94. Sunstar Description and Major Businesses

Table 95. Sunstar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 96. Sunstar Product Model Numbers, Pictures, Descriptions and Specifications

Table 97. Sunstar Recent Developments

Table 98. GSK Company Information

Table 99. GSK Description and Major Businesses

Table 100. GSK Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 101. GSK Product Model Numbers, Pictures, Descriptions and Specifications

Table 102. GSK Recent Developments

Table 103. Bausch Health Company Information

Table 104. Bausch Health Description and Major Businesses

Table 105. Bausch Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 106. Bausch Health Product Model Numbers, Pictures, Descriptions and Specifications

Table 107. Bausch Health Recent Developments

Table 108. Colgate-Palmolive Company Information

Table 109. Colgate-Palmolive Description and Major Businesses

Table 110. Colgate-Palmolive Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 111. Colgate-Palmolive Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Colgate-Palmolive Recent Developments

Table 113. Johnson & Johnson Company Information

Table 114. Johnson & Johnson Description and Major Businesses

Table 115. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 116. Johnson & Johnson Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Johnson & Johnson Recent Developments

Table 118. Roche Company Information

Table 119. Roche Description and Major Businesses

Table 120. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 121. Roche Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Roche Recent Developments

Table 123. Septodont Company Information

Table 124. Septodont Description and Major Businesses

Table 125. Septodont Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 126. Septodont Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Septodont Recent Developments

Table 128. Acteon Company Information

Table 129. Acteon Description and Major Businesses

Table 130. Acteon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 131. Acteon Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Acteon Recent Developments

Table 133. China Resources Double Crane Pharmaceuticals Company Information

Table 134. China Resources Double Crane Pharmaceuticals Description and Major Businesses

Table 135. China Resources Double Crane Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 136. China Resources Double Crane Pharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. China Resources Double Crane Pharmaceuticals Recent Developments

Table 138. Yunnan Baiyao Group Company Information

Table 139. Yunnan Baiyao Group Description and Major Businesses

Table 140. Yunnan Baiyao Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 141. Yunnan Baiyao Group Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Yunnan Baiyao Group Recent Developments

Table 143. Hengrui Medicine Company Information

Table 144. Hengrui Medicine Description and Major Businesses

Table 145. Hengrui Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 146. Hengrui Medicine Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. Hengrui Medicine Recent Developments

Table 148. Key Raw Materials Lists

Table 149. Raw Materials Key Suppliers Lists

Table 150. Distributors List

Table 151. Customers List

Table 152. Market Trends

Table 153. Market Drivers

Table 154. Market Challenges

Table 155. Market Restraints

Table 156. Research Programs/Design for This Report

Table 157. Key Data Information from Secondary Sources

Table 158. Key Data Information from Primary Sources

List of Figures

Figure 1. Dental Anti-inflammatory Drugs Product Picture

Figure 2. Global Dental Anti-inflammatory Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Dental Anti-inflammatory Drugs Market Share by Type: 2024 & 2031

Figure 4. Antibiotics Product Picture

Figure 5. Non-steroidal Anti-inflammatory Drugs Product Picture

Figure 6. Steroidal Anti-inflammatory Drugs Product Picture

Figure 7. Others Product Picture

Figure 8. Global Dental Anti-inflammatory Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 9. Global Dental Anti-inflammatory Drugs Market Share by Application: 2024 & 2031

Figure 10. Online Sales

Figure 11. Hospitals

Figure 12. Pharmacies

Figure 13. Clinics

Figure 14. Others

Figure 15. Dental Anti-inflammatory Drugs Report Years Considered

Figure 16. Global Dental Anti-inflammatory Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 18. Global Dental Anti-inflammatory Drugs Revenue by Region (2020-2031) (US$ Million)

Figure 19. Global Dental Anti-inflammatory Drugs Revenue Market Share by Region in Percentage: 2024 Versus 2031

Figure 20. Global Dental Anti-inflammatory Drugs Revenue Market Share by Region (2020-2031)

Figure 21. Global Dental Anti-inflammatory Drugs Sales (2020-2031) & (K Units)

Figure 22. Global Dental Anti-inflammatory Drugs Sales (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Figure 23. Global Dental Anti-inflammatory Drugs Sales Market Share by Region (2020-2031)

Figure 24. US & Canada Dental Anti-inflammatory Drugs Sales YoY (2020-2031) & (K Units)

Figure 25. US & Canada Dental Anti-inflammatory Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 26. Europe Dental Anti-inflammatory Drugs Sales YoY (2020-2031) & (K Units)

Figure 27. Europe Dental Anti-inflammatory Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 28. China Dental Anti-inflammatory Drugs Sales YoY (2020-2031) & (K Units)

Figure 29. China Dental Anti-inflammatory Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 30. Asia (excluding China) Dental Anti-inflammatory Drugs Sales YoY (2020-2031) & (K Units)

Figure 31. Asia (excluding China) Dental Anti-inflammatory Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 32. Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Sales YoY (2020-2031) & (K Units)

Figure 33. Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Revenue YoY (2020-2031) & (US$ Million)

Figure 34. Global Dental Anti-inflammatory Drugs Sales Share by Manufacturers (2024)

Figure 35. The Dental Anti-inflammatory Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024

Figure 36. Global Dental Anti-inflammatory Drugs Revenue Share by Manufacturers (2024)

Figure 37. The Top 5 and 10 Largest Manufacturers of Dental Anti-inflammatory Drugs in the World: Market Share by Dental Anti-inflammatory Drugs Revenue in 2024

Figure 38. Global Dental Anti-inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 39. Global Dental Anti-inflammatory Drugs Sales Market Share by Type (2020-2031)

Figure 40. Global Dental Anti-inflammatory Drugs Revenue Market Share by Type (2020-2031)

Figure 41. Global Dental Anti-inflammatory Drugs Sales Market Share by Application (2020-2031)

Figure 42. Global Dental Anti-inflammatory Drugs Revenue Market Share by Application (2020-2031)

Figure 43. US & Canada Dental Anti-inflammatory Drugs Sales Market Share by Type (2020-2031)

Figure 44. US & Canada Dental Anti-inflammatory Drugs Revenue Market Share by Type (2020-2031)

Figure 45. US & Canada Dental Anti-inflammatory Drugs Sales Market Share by Application (2020-2031)

Figure 46. US & Canada Dental Anti-inflammatory Drugs Revenue Market Share by Application (2020-2031)

Figure 47. US & Canada Dental Anti-inflammatory Drugs Revenue Share by Country (2020-2031)

Figure 48. US & Canada Dental Anti-inflammatory Drugs Sales Share by Country (2020-2031)

Figure 49. US Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 50. Canada Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 51. Europe Dental Anti-inflammatory Drugs Sales Market Share by Type (2020-2031)

Figure 52. Europe Dental Anti-inflammatory Drugs Revenue Market Share by Type (2020-2031)

Figure 53. Europe Dental Anti-inflammatory Drugs Sales Market Share by Application (2020-2031)

Figure 54. Europe Dental Anti-inflammatory Drugs Revenue Market Share by Application (2020-2031)

Figure 55. Europe Dental Anti-inflammatory Drugs Sales Share by Country (2020-2031)

Figure 56. Europe Dental Anti-inflammatory Drugs Revenue Share by Country (2020-2031)

Figure 57. Germany Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 58. France Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 59. U.K. Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 60. Italy Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 61. Russia Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 62. China Dental Anti-inflammatory Drugs Sales Market Share by Type (2020-2031)

Figure 63. China Dental Anti-inflammatory Drugs Revenue Market Share by Type (2020-2031)

Figure 64. China Dental Anti-inflammatory Drugs Sales Market Share by Application (2020-2031)

Figure 65. China Dental Anti-inflammatory Drugs Revenue Market Share by Application (2020-2031)

Figure 66. Asia Dental Anti-inflammatory Drugs Sales Market Share by Type (2020-2031)

Figure 67. Asia Dental Anti-inflammatory Drugs Revenue Market Share by Type (2020-2031)

Figure 68. Asia Dental Anti-inflammatory Drugs Sales Market Share by Application (2020-2031)

Figure 69. Asia Dental Anti-inflammatory Drugs Revenue Market Share by Application (2020-2031)

Figure 70. Asia Dental Anti-inflammatory Drugs Revenue Share by Region (2020-2031)

Figure 71. Asia Dental Anti-inflammatory Drugs Sales Share by Region (2020-2031)

Figure 72. Japan Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 73. South Korea Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 74. China Taiwan Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 75. Southeast Asia Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 76. India Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 77. Australia Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 78. Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Sales Market Share by Type (2020-2031)

Figure 79. Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Revenue Market Share by Type (2020-2031)

Figure 80. Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Sales Market Share by Application (2020-2031)

Figure 81. Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Revenue Market Share by Application (2020-2031)

Figure 82. Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Revenue Share by Country (2020-2031)

Figure 83. Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Sales Share by Country (2020-2031)

Figure 84. Brazil Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 85. Mexico Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 86. Turkey Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 87. Israel Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 88. GCC Countries Dental Anti-inflammatory Drugs Revenue (2020-2031) & (US$ Million)

Figure 89. Value Chain

Figure 90. Dental Anti-inflammatory Drugs Production Process

Figure 91. Channels of Distribution (Direct Vs Distribution)

Figure 92. Bottom-up and Top-down Approaches for This Report

Figure 93. Data Triangulation

Figure 94. Key Executives Interviewed

目次

This research report focuses on the Dental Anti-inflammatory Drugs Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Dental Anti-inflammatory Drugs Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Dental Anti-inflammatory Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
    • 1.2.2 Antibiotics
    • 1.2.3 Non-steroidal Anti-inflammatory Drugs
    • 1.2.4 Steroidal Anti-inflammatory Drugs
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Dental Anti-inflammatory Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
    • 1.3.2 Online Sales
    • 1.3.3 Hospitals
    • 1.3.4 Pharmacies
    • 1.3.5 Clinics
    • 1.3.6 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Dental Anti-inflammatory Drugs Revenue Estimates and Forecasts 2020-2031
  • 2.2 Global Revenue by Region
    • 2.2.1 Global Dental Anti-inflammatory Drugs Revenue by Region: 2020 VS 2024 VS 2031
    • 2.2.2 Global Dental Anti-inflammatory Drugs Revenue by Region (2020-2031)
    • 2.2.3 Global Dental Anti-inflammatory Drugs Revenue Market Share by Region (2020-2031)
  • 2.3 Global Dental Anti-inflammatory Drugs Sales Estimates and Forecasts 2020-2031
  • 2.4 Global Sales by Region
    • 2.4.1 Global Dental Anti-inflammatory Drugs Sales by Region: 2020 VS 2024 VS 2031
    • 2.4.2 Global Dental Anti-inflammatory Drugs Sales by Region (2020-2031)
    • 2.4.3 Global Dental Anti-inflammatory Drugs Sales Market Share by Region (2020-2031)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

  • 3.1 Global Sales by Manufacturers
    • 3.1.1 Global Dental Anti-inflammatory Drugs Sales by Manufacturers (2020-2025)
    • 3.1.2 Global Dental Anti-inflammatory Drugs Sales Market Share by Manufacturers (2020-2025)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dental Anti-inflammatory Drugs in 2024
  • 3.2 Global Revenue by Manufacturers
    • 3.2.1 Global Dental Anti-inflammatory Drugs Revenue by Manufacturers (2020-2025)
    • 3.2.2 Global Dental Anti-inflammatory Drugs Revenue Market Share by Manufacturers (2020-2025)
    • 3.2.3 Global Top 10 and Top 5 Companies by Dental Anti-inflammatory Drugs Revenue in 2024
  • 3.3 Global Key Players of Dental Anti-inflammatory Drugs, Industry Ranking, 2023 VS 2024
  • 3.4 Global Dental Anti-inflammatory Drugs Sales Price by Manufacturers (2020-2025)
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Dental Anti-inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Dental Anti-inflammatory Drugs, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Dental Anti-inflammatory Drugs, Product Offered and Application
  • 3.8 Global Key Manufacturers of Dental Anti-inflammatory Drugs, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Sales by Type
    • 4.1.1 Global Dental Anti-inflammatory Drugs Historical Sales by Type (2020-2025)
    • 4.1.2 Global Dental Anti-inflammatory Drugs Forecasted Sales by Type (2026-2031)
    • 4.1.3 Global Dental Anti-inflammatory Drugs Sales Market Share by Type (2020-2031)
  • 4.2 Global Revenue by Type
    • 4.2.1 Global Dental Anti-inflammatory Drugs Historical Revenue by Type (2020-2025)
    • 4.2.2 Global Dental Anti-inflammatory Drugs Forecasted Revenue by Type (2026-2031)
    • 4.2.3 Global Dental Anti-inflammatory Drugs Revenue Market Share by Type (2020-2031)
  • 4.3 Global Price by Type
    • 4.3.1 Global Dental Anti-inflammatory Drugs Price by Type (2020-2025)
    • 4.3.2 Global Dental Anti-inflammatory Drugs Price Forecast by Type (2026-2031)

5 Market Size by Application

  • 5.1 Global Sales by Application
    • 5.1.1 Global Dental Anti-inflammatory Drugs Historical Sales by Application (2020-2025)
    • 5.1.2 Global Dental Anti-inflammatory Drugs Forecasted Sales by Application (2026-2031)
    • 5.1.3 Global Dental Anti-inflammatory Drugs Sales Market Share by Application (2020-2031)
  • 5.2 Global Revenue by Application
    • 5.2.1 Global Dental Anti-inflammatory Drugs Historical Revenue by Application (2020-2025)
    • 5.2.2 Global Dental Anti-inflammatory Drugs Forecasted Revenue by Application (2026-2031)
    • 5.2.3 Global Dental Anti-inflammatory Drugs Revenue Market Share by Application (2020-2031)
  • 5.3 Global Price by Application
    • 5.3.1 Global Dental Anti-inflammatory Drugs Price by Application (2020-2025)
    • 5.3.2 Global Dental Anti-inflammatory Drugs Price Forecast by Application (2026-2031)

6 US & Canada

  • 6.1 US & Canada Market Size by Type
    • 6.1.1 US & Canada Dental Anti-inflammatory Drugs Sales by Type (2020-2031)
    • 6.1.2 US & Canada Dental Anti-inflammatory Drugs Revenue by Type (2020-2031)
  • 6.2 US & Canada Market Size by Application
    • 6.2.1 US & Canada Dental Anti-inflammatory Drugs Sales by Application (2020-2031)
    • 6.2.2 US & Canada Dental Anti-inflammatory Drugs Revenue by Application (2020-2031)
  • 6.3 US & Canada Market Size by Country
    • 6.3.1 US & Canada Dental Anti-inflammatory Drugs Revenue by Country: 2020 VS 2024 VS 2031
    • 6.3.2 US & Canada Dental Anti-inflammatory Drugs Revenue by Country (2020-2031)
    • 6.3.3 US & Canada Dental Anti-inflammatory Drugs Sales by Country (2020-2031)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Market Size by Type
    • 7.1.1 Europe Dental Anti-inflammatory Drugs Sales by Type (2020-2031)
    • 7.1.2 Europe Dental Anti-inflammatory Drugs Revenue by Type (2020-2031)
  • 7.2 Europe Market Size by Application
    • 7.2.1 Europe Dental Anti-inflammatory Drugs Sales by Application (2020-2031)
    • 7.2.2 Europe Dental Anti-inflammatory Drugs Revenue by Application (2020-2031)
  • 7.3 Europe Market Size by Country
    • 7.3.1 Europe Dental Anti-inflammatory Drugs Revenue by Country: 2020 VS 2024 VS 2031
    • 7.3.2 Europe Dental Anti-inflammatory Drugs Sales by Country (2020-2031)
    • 7.3.3 Europe Dental Anti-inflammatory Drugs Revenue by Country (2020-2031)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Market Size by Type
    • 8.1.1 China Dental Anti-inflammatory Drugs Sales by Type (2020-2031)
    • 8.1.2 China Dental Anti-inflammatory Drugs Revenue by Type (2020-2031)
  • 8.2 China Market Size by Application
    • 8.2.1 China Dental Anti-inflammatory Drugs Sales by Application (2020-2031)
    • 8.2.2 China Dental Anti-inflammatory Drugs Revenue by Application (2020-2031)

9 Asia (excluding China)

  • 9.1 Asia Market Size by Type
    • 9.1.1 Asia Dental Anti-inflammatory Drugs Sales by Type (2020-2031)
    • 9.1.2 Asia Dental Anti-inflammatory Drugs Revenue by Type (2020-2031)
  • 9.2 Asia Market Size by Application
    • 9.2.1 Asia Dental Anti-inflammatory Drugs Sales by Application (2020-2031)
    • 9.2.2 Asia Dental Anti-inflammatory Drugs Revenue by Application (2020-2031)
  • 9.3 Asia Market Size by Region
    • 9.3.1 Asia Dental Anti-inflammatory Drugs Revenue by Region: 2020 VS 2024 VS 2031
    • 9.3.2 Asia Dental Anti-inflammatory Drugs Revenue by Region (2020-2031)
    • 9.3.3 Asia Dental Anti-inflammatory Drugs Sales by Region (2020-2031)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India
    • 9.3.9 Australia

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Sales by Type (2020-2031)
    • 10.1.2 Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Revenue by Type (2020-2031)
  • 10.2 Middle East, Africa and Latin America Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Sales by Application (2020-2031)
    • 10.2.2 Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Revenue by Application (2020-2031)
  • 10.3 Middle East, Africa and Latin America Market Size by Country
    • 10.3.1 Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Revenue by Country: 2020 VS 2024 VS 2031
    • 10.3.2 Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Revenue by Country (2020-2031)
    • 10.3.3 Middle East, Africa and Latin America Dental Anti-inflammatory Drugs Sales by Country (2020-2031)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Corporate Profile

  • 11.1 3M
    • 11.1.1 3M Company Information
    • 11.1.2 3M Overview
    • 11.1.3 3M Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.1.4 3M Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 3M Recent Developments
  • 11.2 DenMat
    • 11.2.1 DenMat Company Information
    • 11.2.2 DenMat Overview
    • 11.2.3 DenMat Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.2.4 DenMat Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 DenMat Recent Developments
  • 11.3 Merck
    • 11.3.1 Merck Company Information
    • 11.3.2 Merck Overview
    • 11.3.3 Merck Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.3.4 Merck Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Merck Recent Developments
  • 11.4 Bayer
    • 11.4.1 Bayer Company Information
    • 11.4.2 Bayer Overview
    • 11.4.3 Bayer Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.4.4 Bayer Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Bayer Recent Developments
  • 11.5 Sunstar
    • 11.5.1 Sunstar Company Information
    • 11.5.2 Sunstar Overview
    • 11.5.3 Sunstar Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.5.4 Sunstar Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Sunstar Recent Developments
  • 11.6 GSK
    • 11.6.1 GSK Company Information
    • 11.6.2 GSK Overview
    • 11.6.3 GSK Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.6.4 GSK Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 GSK Recent Developments
  • 11.7 Bausch Health
    • 11.7.1 Bausch Health Company Information
    • 11.7.2 Bausch Health Overview
    • 11.7.3 Bausch Health Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.7.4 Bausch Health Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Bausch Health Recent Developments
  • 11.8 Colgate-Palmolive
    • 11.8.1 Colgate-Palmolive Company Information
    • 11.8.2 Colgate-Palmolive Overview
    • 11.8.3 Colgate-Palmolive Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.8.4 Colgate-Palmolive Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Colgate-Palmolive Recent Developments
  • 11.9 Johnson & Johnson
    • 11.9.1 Johnson & Johnson Company Information
    • 11.9.2 Johnson & Johnson Overview
    • 11.9.3 Johnson & Johnson Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.9.4 Johnson & Johnson Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Johnson & Johnson Recent Developments
  • 11.10 Roche
    • 11.10.1 Roche Company Information
    • 11.10.2 Roche Overview
    • 11.10.3 Roche Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.10.4 Roche Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Roche Recent Developments
  • 11.11 Septodont
    • 11.11.1 Septodont Company Information
    • 11.11.2 Septodont Overview
    • 11.11.3 Septodont Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.11.4 Septodont Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Septodont Recent Developments
  • 11.12 Acteon
    • 11.12.1 Acteon Company Information
    • 11.12.2 Acteon Overview
    • 11.12.3 Acteon Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.12.4 Acteon Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Acteon Recent Developments
  • 11.13 China Resources Double Crane Pharmaceuticals
    • 11.13.1 China Resources Double Crane Pharmaceuticals Company Information
    • 11.13.2 China Resources Double Crane Pharmaceuticals Overview
    • 11.13.3 China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.13.4 China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 China Resources Double Crane Pharmaceuticals Recent Developments
  • 11.14 Yunnan Baiyao Group
    • 11.14.1 Yunnan Baiyao Group Company Information
    • 11.14.2 Yunnan Baiyao Group Overview
    • 11.14.3 Yunnan Baiyao Group Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.14.4 Yunnan Baiyao Group Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 Yunnan Baiyao Group Recent Developments
  • 11.15 Hengrui Medicine
    • 11.15.1 Hengrui Medicine Company Information
    • 11.15.2 Hengrui Medicine Overview
    • 11.15.3 Hengrui Medicine Dental Anti-inflammatory Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
    • 11.15.4 Hengrui Medicine Dental Anti-inflammatory Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.15.5 Hengrui Medicine Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Dental Anti-inflammatory Drugs Industry Chain Analysis
  • 12.2 Dental Anti-inflammatory Drugs Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Dental Anti-inflammatory Drugs Production Mode & Process
  • 12.4 Dental Anti-inflammatory Drugs Sales and Marketing
    • 12.4.1 Dental Anti-inflammatory Drugs Sales Channels
    • 12.4.2 Dental Anti-inflammatory Drugs Distributors
  • 12.5 Dental Anti-inflammatory Drugs Customers

13 Dental Anti-inflammatory Drugs Market Dynamics

  • 13.1 Dental Anti-inflammatory Drugs Industry Trends
  • 13.2 Dental Anti-inflammatory Drugs Market Drivers
  • 13.3 Dental Anti-inflammatory Drugs Market Challenges
  • 13.4 Dental Anti-inflammatory Drugs Market Restraints

14 Key Findings in the Global Dental Anti-inflammatory Drugs Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 15.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Author Details
  • 15.3 Disclaimer